We're a Gold Sponsor
at DDL 2019 Edinburgh
11th - 13th December
Come and join us
Produced to the most demanding industry standards at dedicated facilities, Zephex® propellants are used in around 75% of the world’s metered dose inhalers.
This commitment to the highest levels of medical propellant quality is supported by a detailed understanding of customer requirements and experienced staff with many years of technical expertise.
Landmark multi-million-pound sterling commercial agreement will advance efforts to bring Zephex®152a from the laboratory to the patient Runcorn (United Kingdom) December 2019 – Koura, the leading medical propellant manufacturer (previously known as Mexichem Fluor), has today announced a commercial agreement to supply the new…
Global innovators and world leaders in medical propellants, Koura, will showcase its industry-leading products at The Drug Delivery to the Lungs (DDL) Conference as a Gold Sponsor.
Koura are Gold sponsors at 2019’s Inhalation Asia in Hong Kong this November 13th-15th